ADC Therapeutics SA (ADCT) insider trading.
In Q3 2026, insiders at ADC Therapeutics SA reported 4 non-derivative transactions on 4 Forms 3, 4 and 5: 0 open-market purchases and 0 sales.
- Transactions
- 4
- Purchases (P)
- 0
- Sales (S)
- 0
- Net shares, P minus S
- 0
- Insiders
- 4
- Last filed
- 2026-07-02
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Mallik Ameet | Director, Officer · Chief Executive Officer | 1 | 0 | 0 |
| Carmona Jose | Officer · Chief Financial Officer | 1 | 0 | 0 |
| Graham Peter J | Officer · Chief Legal Officer | 1 | 0 | 0 |
| Zaki Mohamed | Officer · Chief Medical Officer | 1 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-06-30 | Mallik Ameet | A (A) | 675,000 | $0 | 2,121,769 | Form 4 |
| 2026-06-30 | Carmona Jose | A (A) | 203,700 | $0 | 938,076 | Form 4 |
| 2026-06-30 | Graham Peter J | A (A) | 221,100 | $0 | 841,640 | Form 4 |
| 2026-06-30 | Zaki Mohamed | A (A) | 213,900 | $0 | 896,317 | Form 4 |
Transaction codes in this quarter
Get ADCT insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1771910&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · ADCT company page · ADC Therapeutics SA on SEC.gov
Questions
Are insiders buying or selling ADC Therapeutics SA (ADCT)?
In Q3 2026, insiders at ADC Therapeutics SA reported 4 non-derivative transactions on 4 Forms 3, 4 and 5: 0 open-market purchases and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these ADC Therapeutics SA insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/adct.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.